LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 100

Search options

  1. Article ; Online: In vitro bioaccessibility round robin testing for arsenic and lead in standard reference materials and soil samples.

    Dodd, Matt / Lee, Deanna / Nelson, Jasen / Verenitch, Sergei / Wilson, Ross

    Integrated environmental assessment and management

    2024  

    Abstract: In this study, we assessed the suitability of using a standard reference material (SRM) other than National Institute of Standards and Technology (NIST) 2710a or NIST 2711a in USEPA Method 1340 to determine arsenic (As) and lead (Pb) in vitro ... ...

    Abstract In this study, we assessed the suitability of using a standard reference material (SRM) other than National Institute of Standards and Technology (NIST) 2710a or NIST 2711a in USEPA Method 1340 to determine arsenic (As) and lead (Pb) in vitro bioaccessibility (IVBA) and the capabilities of Canadian-based laboratories to perform the method. Five laboratories participated in an initial round robin study and analyzed NIST 2710a, NIST 2711a, BGS119, and Enviromat SS-2. Intra- and inter-laboratory variability were generally acceptable with percentage relative standard deviations (RSD) of less than 20%. The mean total As and Pb concentrations obtained for BGS119 (332 and 936 mg/kg, respectively) and the mean IVBA values (As = 14.3% and Pb = 78.1%) suggested it may be a suitable and acceptable SRM, whereas the concentration of As in Enviromat SS-2 as received (3.2 mg/kg) was deemed too low. Ten soil samples from sites with varying land use were analyzed in a follow-up round robin study using the modified IVBA method that included BGS119 as SRM. The concentrations of As and Pb in the IVBA extracts reported by the participating laboratories were comparable. The mean As IVBA values for the field-collected samples ranged from 0.1% to 56.4%; for Pb, they ranged from 7.0% to 121%. The lowest IVBA values were measured in mine site samples; the highest values were associated with smelter-affected soils. The low IVBA values correlated with high iron content. Intra- and interlaboratory reproducibility were acceptable (RSD < 30%). Based on the findings of the study, laboratories can use the modified method to provide reproducible and comparable As and Pb IVBA data. The use of BGS119 as an alternative SRM to assess contaminated sites in the province of British Columbia for regulatory purposes is recommended, as it is representative of As and Pb concentrations in contaminated soils in British Columbia. Integr Environ Assess Manag 2024;00:1-10. © 2024 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
    Language English
    Publishing date 2024-02-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2234931-5
    ISSN 1551-3793 ; 1551-3777
    ISSN (online) 1551-3793
    ISSN 1551-3777
    DOI 10.1002/ieam.4891
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Epidemiology of cruciate ligament injuries in New Zealand: exploring differences by ethnicity and socioeconomic status.

    Pryymachenko, Yana / Wilson, Ross / Abbott, J Haxby

    Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention

    2022  Volume 29, Issue 3, Page(s) 213–218

    Abstract: Objectives: To investigate the temporal trends and ethnic and socioeconomic disparities in cruciate ligament (CL) injury incidence and associated costs in New Zealand over a 14-year period.: Methods: All CL injury claims lodged between 2007 and 2020 ... ...

    Abstract Objectives: To investigate the temporal trends and ethnic and socioeconomic disparities in cruciate ligament (CL) injury incidence and associated costs in New Zealand over a 14-year period.
    Methods: All CL injury claims lodged between 2007 and 2020 were extracted from the Accident Compensation Corporation (a nationwide no-fault injury compensation scheme) claims dataset. Age-adjusted and sex-adjusted incidence rates, total injury costs and costs per claim were calculated for each year for total population and subgroups.
    Results: The total number of CL injury claims increased from 6972 in 2007 to 8304 in 2019, then decreased to 7068 in 2020 (likely due to widespread COVID-19 restrictions; analysis is therefore restricted to 2007-2019 hereafter). The (age-adjusted and sex-adjusted) incidence rate remained largely unchanged and was 173 cases per 100 000 people in 2019. There was a 127% increase in total injury claims costs and a 90% increase in costs per claim. Pacific people had the highest incidence rate and costs per 100 000 people, while Asians had the lowest; European, Māori and 'other' ethnicities had similar incidence rates and total costs. Incidence rates and total costs increased with income and decreased with neighbourhood deprivation. Costs per claim differed little by ethnicity, but increased with income level.
    Conclusion: The number and costs of CL injury claims in New Zealand are increasing. There are ethnic and socioeconomic disparities in CL incidence rates and costs, which are important to address when designing CL injury prevention programmes and programmes aimed at improving equity of access to medical care.
    MeSH term(s) Humans ; COVID-19 ; Ethnicity ; Incidence ; Ligaments/injuries ; Maori People ; New Zealand/epidemiology ; Social Class ; European People ; Asian People
    Language English
    Publishing date 2022-12-23
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1433667-4
    ISSN 1475-5785 ; 1353-8047
    ISSN (online) 1475-5785
    ISSN 1353-8047
    DOI 10.1136/ip-2022-044761
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The projected burden of knee osteoarthritis in New Zealand: healthcare expenditure and total joint provision-a response.

    Abbott, Haxby / Wilson, Ross

    The New Zealand medical journal

    2020  Volume 133, Issue 1509, Page(s) 77–78

    MeSH term(s) Arthroplasty, Replacement ; Arthroplasty, Replacement, Knee ; Health Expenditures ; Humans ; New Zealand ; Osteoarthritis, Knee/surgery
    Language English
    Publishing date 2020-02-07
    Publishing country New Zealand
    Document type Letter ; Comment
    ZDB-ID 390590-1
    ISSN 1175-8716 ; 0028-8446 ; 0110-7704
    ISSN (online) 1175-8716
    ISSN 0028-8446 ; 0110-7704
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Who should judge treatment effects as unimportant?

    Abdel Shaheed, Christina / Mathieson, Stephanie / Wilson, Ross / Furmage, Ann-Mason / Maher, Christopher G

    Journal of physiotherapy

    2023  Volume 69, Issue 3, Page(s) 133–135

    Language English
    Publishing date 2023-05-30
    Publishing country Netherlands
    Document type Editorial
    ZDB-ID 2543915-7
    ISSN 1836-9561 ; 1836-9553 ; 0004-9514
    ISSN (online) 1836-9561
    ISSN 1836-9553 ; 0004-9514
    DOI 10.1016/j.jphys.2023.04.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Daunting Economics of Therapeutic Genome Editing.

    Wilson, Ross C / Carroll, Dana

    The CRISPR journal

    2019  Volume 2, Issue 5, Page(s) 280–284

    Abstract: There is no shortage of enthusiasm for the clinical potential of CRISPR-based genome editing: many life-changing cures appear to be just around the corner. However, as mature genetic therapies reach the market, it seems that million-dollar price tags are ...

    Abstract There is no shortage of enthusiasm for the clinical potential of CRISPR-based genome editing: many life-changing cures appear to be just around the corner. However, as mature genetic therapies reach the market, it seems that million-dollar price tags are the new normal. Several factors contribute to the extreme pricing of next-generation medicines, including the need to recoup development costs, the undeniable value of these powerful therapies, and the inherent technical challenges of manufacture and delivery. CRISPR technology has been hailed as a great leveler and a democratizing force in biomedicine. But for this principle to hold true in clinical contexts, therapeutic genome editing must avoid several pitfalls that could substantially limit access to its transformative potential, especially in the developing world.
    MeSH term(s) CRISPR-Cas Systems ; Gene Editing/economics ; Gene Editing/ethics ; Genetic Engineering/economics ; Genetic Engineering/ethics ; Genetic Therapy/economics ; Genome ; Genome, Human/genetics ; Genomics/economics ; Genomics/ethics ; Germ Cells/metabolism ; Germ Cells/physiology ; Humans
    Language English
    Publishing date 2019-10-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3017891-5
    ISSN 2573-1602 ; 2573-1599
    ISSN (online) 2573-1602
    ISSN 2573-1599
    DOI 10.1089/crispr.2019.0052
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The long-term impacts of opioid use before and after joint arthroplasty: matched cohort analysis of New Zealand linked register data.

    Pryymachenko, Yana / Wilson, Ross / Haxby Abbott, John / Dowsey, Michelle / Choong, Peter

    Family practice

    2023  

    Abstract: Background: Opioids are commonly used both before and after total joint arthroplasty (TJA).: Objective: The objective of this study was to estimate the long-term effects of pre- and perioperative opioid use in patients undergoing TJA.: Methods: We ...

    Abstract Background: Opioids are commonly used both before and after total joint arthroplasty (TJA).
    Objective: The objective of this study was to estimate the long-term effects of pre- and perioperative opioid use in patients undergoing TJA.
    Methods: We used linked population datasets to identify all (n =18,666) patients who had a publicly funded TJA in New Zealand between 2011 and 2013. We used propensity score matching to match individuals who used opioids either before surgery, during hospital stay, or immediately post-discharge with individuals who did not based on a comprehensive set of covariates. Regression analysis was used to estimate the effect of opioid use on health and socio-economic outcomes over 5 years.
    Results: Opioid use in the 3 months prior to surgery was associated with significant increases in healthcare utilization and costs (number of hospitalizations 6%, days spent in hospital 14.4%, opioid scripts dispensed 181%, and total healthcare costs 11%). Also increased were the rate of receiving social benefits (2 percentage points) and the rates of opioid overdose (0.5 percentage points) and mortality (3 percentage points). Opioid use during hospital stay or post-discharge was associated with increased long-term opioid use, but there was little evidence of other adverse effects.
    Conclusions: Opioid use before TJA is associated with significant negative health and economic consequences and should be limited. This has implications for opioid prescribing in primary care. There is little evidence that peri- or post-operative opioid use is associated with significant long-term detriments.
    Language English
    Publishing date 2023-12-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 605939-9
    ISSN 1460-2229 ; 0263-2136
    ISSN (online) 1460-2229
    ISSN 0263-2136
    DOI 10.1093/fampra/cmad112
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Is recursive "mindreading" really an exception to limitations on recursive thinking?

    Wilson, Ross / Hruby, Ales / Perez-Zapata, Daniel / van der Kleij, Sanne W / Apperly, Ian A

    Journal of experimental psychology. General

    2023  Volume 152, Issue 5, Page(s) 1454–1468

    Abstract: The ability to mindread recursively-for example, by thinking what person 1 thinks person 2 thinks person 3 thinks-is a prime example of recursive thinking in which one process, representation, or idea becomes embedded within a similar one. It has also ... ...

    Abstract The ability to mindread recursively-for example, by thinking what person 1 thinks person 2 thinks person 3 thinks-is a prime example of recursive thinking in which one process, representation, or idea becomes embedded within a similar one. It has also been suggested that mindreading is an exceptional example, with five recursive steps commonly observed for mindreading, in comparison with just one or two in other domains. However, conceptual analysis of existing recursive mindreading tasks suggests that conclusions about exceptional mindreading are insecure. Revised tasks were devised to provide a more rigorous test of recursive mindreading capacity. Study 1 (
    MeSH term(s) Humans ; Problem Solving ; Communication
    Language English
    Publishing date 2023-03-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 189732-9
    ISSN 1939-2222 ; 0096-3445
    ISSN (online) 1939-2222
    ISSN 0096-3445
    DOI 10.1037/xge0001322
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The projected burden of knee osteoarthritis in New Zealand: healthcare expenditure and total joint replacement provision.

    Wilson, Ross / Abbott, J Haxby

    The New Zealand medical journal

    2019  Volume 132, Issue 1503, Page(s) 53–65

    Abstract: Aim: To estimate the healthcare costs and demand for total knee replacement (TKR) associated with knee osteoarthritis in New Zealand over the period 2013-2038 and the contribution of increasing obesity rates to these costs.: Method: We used the NZ- ... ...

    Abstract Aim: To estimate the healthcare costs and demand for total knee replacement (TKR) associated with knee osteoarthritis in New Zealand over the period 2013-2038 and the contribution of increasing obesity rates to these costs.
    Method: We used the NZ-MOA computer simulation model of knee osteoarthritis in the New Zealand population. Osteoarthritis-related healthcare costs and TKR incidence were modelled for a 25-year horizon, for a starting cohort drawn from the 2013 New Zealand population. Population obesity projections were used to estimate the life-course of cohort obesity. Per-person projected outcomes were multiplied by national demographic population projections to obtain total population projections.
    Results: Healthcare costs of knee osteoarthritis were projected to increase from NZ$199 million in 2013 to $370 million in 2038. Annual TKR incidence was projected to increase from 5,070 to 9,040 over the same period. Projected increases in population obesity rates (above the obesity prevalence seen in 2013) accounted for 25% and 47% of the projected increase in per-capita healthcare costs and TKR provision rates, respectively.
    Conclusion: The healthcare burden of knee OA will continue to increase for the foreseeable future. Public health measures to reduce further increases in population obesity rates would contribute to slowing this rising burden.
    MeSH term(s) Arthroplasty, Replacement, Knee/economics ; Arthroplasty, Replacement, Knee/statistics & numerical data ; Computer Simulation/statistics & numerical data ; Female ; Health Care Costs/statistics & numerical data ; Health Services Needs and Demand/trends ; Humans ; Male ; Middle Aged ; New Zealand/epidemiology ; Obesity/epidemiology ; Osteoarthritis, Knee/economics ; Osteoarthritis, Knee/epidemiology ; Osteoarthritis, Knee/psychology ; Osteoarthritis, Knee/surgery ; Prognosis ; Quality of Life ; Reproducibility of Results ; Risk Factors
    Language English
    Publishing date 2019-10-04
    Publishing country New Zealand
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 390590-1
    ISSN 1175-8716 ; 0028-8446 ; 0110-7704
    ISSN (online) 1175-8716
    ISSN 0028-8446 ; 0110-7704
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Does governance cause growth?

    Wilson, Ross

    World development : the multi-disciplinary international journal devoted to the study and promotion of world development Vol. 79 , p. 138-151

    evidence from China

    2016  Volume 79, Page(s) 138–151

    Author's details Ross Wilson
    Keywords Asia ; China ; quality of governance ; economic growth
    Language English
    Publisher Elsevier Science
    Publishing place Amsterdam
    Document type Article
    ZDB-ID 185339-9 ; 1500836-8
    ISSN 0305-750X
    ISSN 0305-750X
    Database ECONomics Information System

    More links

    Kategorien

  10. Article ; Online: Emerging Strategies for Genome Editing in the Brain.

    Foss, Dana V / Wilson, Ross C

    Trends in molecular medicine

    2018  Volume 24, Issue 10, Page(s) 822–824

    Abstract: Despite the unparalleled therapeutic promise of genome editing, its curative power is currently limited by the substantial difficulty in delivering DNA-cutting enzymes to the cells in need of correction. A recent study demonstrates the potential for the ... ...

    Abstract Despite the unparalleled therapeutic promise of genome editing, its curative power is currently limited by the substantial difficulty in delivering DNA-cutting enzymes to the cells in need of correction. A recent study demonstrates the potential for the delivery of pre-assembled genome-editing enzymes in the form of ribonucleoprotein complexes, which were used to rescue a mouse model of fragile X syndrome (FXS).
    MeSH term(s) Animals ; Biological Transport ; Brain/metabolism ; Brain/pathology ; CRISPR-Associated Protein 9/genetics ; CRISPR-Associated Protein 9/metabolism ; CRISPR-Cas Systems ; Clustered Regularly Interspaced Short Palindromic Repeats ; Dependovirus/genetics ; Dependovirus/metabolism ; Disease Models, Animal ; Fragile X Mental Retardation Protein/genetics ; Fragile X Mental Retardation Protein/metabolism ; Fragile X Syndrome/genetics ; Fragile X Syndrome/metabolism ; Fragile X Syndrome/pathology ; Fragile X Syndrome/therapy ; Gene Deletion ; Gene Editing/methods ; Gene Transfer Techniques ; Gold/administration & dosage ; Gold/chemistry ; Gold/metabolism ; Humans ; Metal Nanoparticles/administration & dosage ; Metal Nanoparticles/chemistry ; Mice ; Mice, Knockout ; Ribonucleoproteins/genetics ; Ribonucleoproteins/metabolism
    Chemical Substances Fmr1 protein, mouse ; Ribonucleoproteins ; Fragile X Mental Retardation Protein (139135-51-6) ; Gold (7440-57-5) ; CRISPR-Associated Protein 9 (EC 3.1.-)
    Language English
    Publishing date 2018-08-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 2036490-8
    ISSN 1471-499X ; 1471-4914
    ISSN (online) 1471-499X
    ISSN 1471-4914
    DOI 10.1016/j.molmed.2018.07.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top